BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Treatment
54 results:

  • 1. Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients.
    Stepien N; Mayr L; Schmook MT; Raimann A; Dorfer C; Peyrl A; Azizi AA; Schramm K; Haberler C; Gojo J
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30836. PubMed ID: 38177074
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Systematic review and cumulative analysis of clinical properties of BRAF V600E mutations in PLNTY histological samples.
    Baumgartner ME; Lang SS; Tucker AM; Madsen PJ; Storm PB; Kennedy BC
    Childs Nerv Syst; 2024 May; 40(5):1361-1366. PubMed ID: 38150037
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer's disease.
    Zhi J; Yin L; Zhang Z; Lv Y; Wu F; Yang Y; Zhang E; Li H; Lu N; Zhou M; Hu Q
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117291. PubMed ID: 37925002
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ethanolic Extract of
    Sayuti NH; Zulkefli N; Tan JK; Saad N; Baharum SN; Hamezah HS; Bunawan H; Ahmed QU; Parveen H; Mukhtar S; Alsharif MA; Sarian MN
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764502
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease.
    Matošević A; Opsenica DM; Spasić M; Maraković N; Zandona A; Žunec S; Bartolić M; Kovarik Z; Bosak A
    Chem Biol Interact; 2023 Sep; 382():110620. PubMed ID: 37406982
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
    Kovács SA; Fekete JT; Győrffy B
    Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer's disease.
    Bhanukiran K; T A G; Krishnamurthy S; Singh SK; Hemalatha S
    Eur J Med Chem; 2023 Mar; 249():115145. PubMed ID: 36706620
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases.
    Demleitner M; Erlenbach-Wünsch K; Coras R; Erber R; Polifka I; Eyüpoğlu I; Fuchs F; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2023 Apr; 63():152082. PubMed ID: 36634550
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of upregulated genes in glioblastoma and glioblastoma cancer stem cells using bioinformatics analysis.
    Caglar HO; Duzgun Z
    Gene; 2023 Jan; 848():146895. PubMed ID: 36122609
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Neuroprotective effects of total alkaloids fraction of Huperzia serrata on scopolamine-induced neurodegenerative animals.
    Dang TK; Hong SM; Dao VT; Nguyen DT; Nguyen KV; Nguyen HT; Ullah S; Tran HT; Kim SY
    Phytother Res; 2023 Jan; 37(1):140-150. PubMed ID: 36065796
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
    Hernandez A; Muñoz-Mármol AM; Esteve-Codina A; Alameda F; Carrato C; Pineda E; Arpí-Lluciá O; Martinez-García M; Mallo M; Gut M; Del Barco S; Gallego O; Dabad M; Mesia C; Bellosillo B; Domenech M; Vidal N; Aldecoa I; de la Iglesia N; Balana C
    Sci Rep; 2022 Aug; 12(1):14439. PubMed ID: 36002559
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dioscin alleviates Alzheimer's disease through regulating RAGE/NOX4 mediated oxidative stress and inflammation.
    Guan L; Mao Z; Yang S; Wu G; Chen Y; Yin L; Qi Y; Han L; Xu L
    Biomed Pharmacother; 2022 Aug; 152():113248. PubMed ID: 35691153
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anoectochilus roxburghii flavonoids extract ameliorated the memory decline and reduced neuron apoptosis via modulating SIRT1 signaling pathway in senescent mice.
    Zeng Z; Chen C; SiTu Y; Shen Z; Chen Y; Zhang Z; Tang C; Jiang T
    J Ethnopharmacol; 2022 Oct; 296():115361. PubMed ID: 35609756
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics.
    Vagvala S; Guenette JP; Jaimes C; Huang RY
    Cancer Imaging; 2022 Apr; 22(1):19. PubMed ID: 35436952
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Oncogenic Fusions in Gliomas: An Institutional Experience.
    Polivka J; Svajdler M; Priban V; Mracek J; Kasik P; Martinek P; Ptakova N; Sharif Bagheri M; Shetti D; Pesta M; Potuznik P; Topolcan O
    Anticancer Res; 2022 Apr; 42(4):1933-1939. PubMed ID: 35347013
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
    Lassman AB; Sepúlveda-Sánchez JM; Cloughesy TF; Gil-Gil MJ; Puduvalli VK; Raizer JJ; De Vos FYF; Wen PY; Butowski NA; Clement PMJ; Groves MD; Belda-Iniesta C; Giglio P; Soifer HS; Rowsey S; Xu C; Avogadri F; Wei G; Moran S; Roth P
    Clin Cancer Res; 2022 Jun; 28(11):2270-2277. PubMed ID: 35344029
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HSP90-CDC37 functions as a chaperone for the oncogenic fgfr3-TACC3 fusion.
    Li T; Mehraein-Ghomi F; Forbes ME; Namjoshi SV; Ballard EA; Song Q; Chou PC; Wang X; Parker Kerrigan BC; Lang FF; Lesser G; Debinski W; Yang X; Zhang W
    Mol Ther; 2022 Apr; 30(4):1610-1627. PubMed ID: 35151844
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting gene fusions in glioma.
    Kim PL
    Curr Opin Neurol; 2021 Dec; 34(6):840-847. PubMed ID: 34766555
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Precise editing of fgfr3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma.
    Wu Y; Jin W; Wang Q; Zhou J; Wang Y; Tan Y; Cui X; Tong F; Yang E; Wang J; Kang C
    Mol Ther; 2021 Nov; 29(11):3305-3318. PubMed ID: 34274537
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.
    Ohmoto A; Sato Y; Asaka R; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takeuchi K; Mori S; Takahashi S
    Mod Pathol; 2021 Nov; 34(11):1979-1989. PubMed ID: 34247193
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.